Menu Back toSession-1-Regulatory-Trends-in-Clinical-Safety-Pharmacovigilance

DIA India 7th Pharmacovigilance Conference

At this event, DIA India brings together key regulatory authorities, leading industry subject matter experts and thought leaders for collaborative discussions on driving innovation in drug safety and pharmacovigilance.

Session # 1- Regulatory Trends in Clinical Safety & Pharmacovigilance

Session Chair(s)

J Vijay  Venkatraman, MD, MBA

J Vijay Venkatraman, MD, MBA

  • Managing Director and CEO
  • Oviya MedSafe, India


Mangesh  Kulkarni, MD

Mangesh Kulkarni, MD

  • Head Drug Safety
  • Tata Consultancy Services, India
Seema  Jaitly, DrMed

Brexit and Its Pharmacovigilance After Effects

Seema Jaitly, DrMed

  • Managing Director
  • Essjay Solutions Ltd, United Kingdom
Punit  Wason

Resolving the R3 Tangle

Punit Wason

  • Sr. Manager
  • High Point Solutions, An IQVIA Company, India